Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related halogenated aromatic hydrocarbons (HAHs) are industrial compounds or by-products that have been identified as contaminants in almost every component ofthe global ecosystem. 2, 3, 7, is the most toxic HAH, and studies in rodents have shown that this compound is a carcinogen. Analysis of environmental samples for HAHs has shown that these extracts contain complex mixtures of isomers and congeners, and this greatly complicates risk assessment due to the paucity of data available for most of the individual compounds. Extensive research has demonstrated a common receptor-mediated mechanism of action for TCDD and related toxic HAHs, and this has led to the development of a mechanism-based risk assessment approach for HAHs. Toxic equivalency factors (TEFs; relative potency compared to TCDD) have been developed for selected HAH congeners, and the TEF values can be used to determine "toxic equivalents" (TEQs) for HAH mixtures. In addition, several bioassays that use receptor-mediated end points have been developed and can be used directly to determine the TEQs for HAH mixtures. The applications ofthe TEF/TEQ approach for the risk assessment of HAHs are considerable, particularly with the conversion of complex analytical data into TEQs. However, there appear to be several limitations to this approach, particularly with PCBs because their potential nonadditive (antagonistic), interactive effects with "2,3,7,8-TCDD-like" compounds may invalidate the use of the risk assessment procedure for some environmental matrices.
Introduction
Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), and dibenzofurans (PCDFs) (Fig. 1 ) are halogenated aromatic compounds that have been identified as contaminants in almost every component of the global ecosystem including the air, aquatic and marine sediments, fish, wildlife and human adipose tissue, milk, and blood (1) (2) (3) (4) (5) . PCBs were widely used as industrial compounds and have entered the enviromnent via numerous pathways including direct leakage from industrial facilities or machinery that used PCBs, leakage from waste sites containing PCB fluids, accidents, and spills. In contrast, PCDDs and PCDFs are industrial by-products that are formed during the production of chlorinated phenols and their derived products, PCBs and other chlorinated organic compounds. PCDDs and PCDFs have also been identified as by-products from the combustion of municipal and industrial waste, wood, coal, and numerous other combustion processes. In addition, PCDDs and PCDFs are formed as by-products during the bleaching of wood and pulp paper, and residues of these compounds have been detected in pulp mill effluent and sludges, pulp samples, finished paper products, and aquatic sediments associated with discharges from pulp and paper mills (1) (2) (3) (4) (5) (6) (7) .
The structures of individual PCB, PCDD, and PCDF congeners differ by their degree of chlorination and the ring substitution patterns, and Thble 1 illustrates the large number of possible isomers and congeners for these chemical classes. There are 209 individual PCBs, and recent high-resolution analytical studies (8) have identifled 132 of Table 1 . Multiplicity of PCB, PCDF, and PCDD isomers and congeners.
No . of C1 atoms  1  2  3  4  5  6  7  8  9  10  Total  PCBs  3  12  24  42  46  42  24  12  3  1  209  PCDFs  4  16  28  38  28  16  4  1   --135  PCDDs  2  10  14  22  14  10  2  1   --75 these compounds in the commercial mixtures. The composition of the PCDD and PCDF by-products are highly variable and dependent on their source. For example, the PCDDs and PCDFs that have been identified as byproducts of combustion are complex mixtures of isomers and congeners. In contrast, the PCDDs and PCDFs found as contarrminants in many chlorinated phenol preparations are less complex and dependent on the structures of the chlorinated phenol precursors (7) . For example, the highly toxic 2, Environmental Impact of PCBs, PCDDs, and PCDFs
PCBs were first detected in the environment in the midto late-1960s as unidentified peaks that were observed during the gas chromatographic analysis of environmental extracts for DDT and related metabolites and breakdown products (9, 10) . Subsequent studies have identified PCBs as residues in almost all environmental samples. Early packed-column gas chromatographic analysis of the commercial PCBs and PCB residues from diverse environmental extracts demonstrated the complex composition of these mixtures (8) (9) (10) (11) ; moreover, recent studies using high-resolution analytical methods have confirmed that commercial PCB mixtures and the PCB residues in environmental extracts are highly complex. Inspection of the chromatograms of PCB residues from environmental extracts and from the commercial mixtures clearly demonstrates that the congener composition of the extracts does not resemble that of any single commercial PCB or their reconstituted mixtures. PCBs associated with atmospheric samples tend to contain some of the more volatile lower-chlorinated congeners, whereas the PCB composition of extracts from water and sediment samples can be highly variable and depend, in part, on the relative rates of microbial breakdown processes associated with these environments (15) (16) (17) .
Safe and co-workers (18) first reported that the dominant PCB congeners (> 5%) in a composite human milk sample from Michigan were 2,4,4'-trichlorobiphenyl, 2,4,4',5-tetrachlorobiphenyl, 2,3',4,4',5-pentachlorobiphenyl, 2,2' ,3,4,4' ,5'-hexachlorobiphenyl, 2,2' ,4,4' ,5,5'-hexachlorobiphenyl, 2,2',3,3',4,4',5-heptachloiobiphenyl, and 2,2' ,3,4,4',5,5'-heptachlorobiphenyl. These compounds constituted 58.9% of the total PCBs in the human milk extract; however, at least 55 different PCBs were identified. Ruarte-Davidson and co-workers (19) reported that a similar set of PCB congeners were identified in human tissue samples from several different locations, and many of these same compounds are major PCB components in wildlife samples. The differences in composition between the PCBs in various environmental samples is no doubt due to differential congener solubility, chemical and photochemical degradability, volatility, uptake, disposition, and metabolism. Thus, although samples from the same environmental matrix taken from different locations may contain a similar set of congeners, their relative composition will be variable.
PCDDs and PCDFs have also been widely identified in extracts of environmental samples and the composition of these analytes depend on their origins (e.g., air, water, sediments, or biota) and inputs from nearby sources (1, 2, 20, 21) . Several studies have reported the PCDD and PCDF composition of atmospheric samples from both urban industrial and rural areas (22) (23) (24) (25) (26) (27) (28) . The absolute concentrations of the sum of PCDDs and PCDFs depend on local or regional inputs; however, the congener distribution pattern for most atmospheric samples resembles a typical combustion pattern for these compounds. Rappe and co-workers (22, 24) reported the PCDD and PCDF content in several atmospheric particulate samples and only slight variations were observed: for example, the E PCDDs > X PCDFs; octachlorodibenzo-p-dioxin (OCDD) and heptachlorodibenzo-p-dioxin (HpCDD) were the dominant PCDDs with lower levels of the hexa-, penta-, and tetrachlorodibenzo-p-dioxins (HCDD, PeCDD and TCDD). In contrast, the tetra-and pentachlorodibenzofurans (TCDF and PeCDF) are the dominant PCDFs with lower levels of the octa-, hepta-, and hexachlorodibenzofurans (OCDF, HpCDF, and HCDF). Similar patterns of PCDD/PCDF distribution have been detected in soil samples (29) and on the outer surfaces of pine needles, which can be used as a biomonitor of atmospheric PCDDs, PCDFs, PCBs, and related organic contaminants (30) (31) (32) .
In contrast, only the 2,3,7,8-substituted PCDDs and PCDFs are routinely detected in fish, wildlife, and human samples (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) . The levels of PCDDs and PCDFs in biotic samples can vary depending on local contamination sources. In general, the pattern of these compounds in extracts from human samples resemble, in part, the combustion and atmospheric pattern, with OCDD being the dominant congener ( sediments (43) (44) (45) and the low to nondetectable levels in fish indicate that OCDD is not readily absorbed and/or retained in fish tissue. In summary, it is evident that the PCBs, PCDD, and PCDFs in the environment and human tissues are present as complex mixtures of isomers and congeners, and risk assessment approaches for these compounds must take into account this feature of congener multiplicity.
Common Biochemical and Toxic Responses and Mechanism of Action Biochemical and Toxic Responses
The biochemical and toxic responses elicited by commercial PCBs, PCDDs, and PCDF mixtures and individual congeners are somewhat variable and can depend on the structure of the individual compound and the degree of chlorination of the PCB mixture. However, it has been demonstrated that specific mixtures and individual PCB, PCDD, and PCDF congeners elicit a comparable spectrum of toxic and biochemical responses in laboratory animals, humans, and mammalian cells in culture (6, (46) (47) (48) (49) (50) (51) (52) (53) (54) (55) (56) (57) (6, 56) . These data confirm the utility of the in vitro induction assays as short-term test systems for the quantitative analysis of the toxicity of individual PCDD, PCB, and PCDF congeners and their mixtures. Moreover, these data and the results of numerous other studies also provide the essential mechanistic-based framework for the development of the TEF approach for the hazard and risk assessment of these compounds (6 Table 3 summarize the range of relative potencies of the more highly toxic PCDD, PCDF, and PCB congeners, which have been derived from numerous in vivo animal studies and in vitro bioassays (6) . The results demonstrate that all of the compounds are less toxic than 2,3,7,8-TCDD and that for each congener there is a range of potencies relative to that of 2,3,7,8-TCDD. There is a wide variation in the range of these TEF values for different congeners, and the variability of the TEFs depend on several factors including the nature of the response, the animal or mammalian test system used, the route of exposure, and the duration of the experiment. The relative pharmacokinetics and metabolism of individual PCB, PCDD, and PCDF congeners may depend on the strain, sex, age, and species used and the target organ, and these factors no doubt contribute to the wide range of potencies of these congeners relative to that of 2,3,7,8-TCDD. Nevertheless, several regulatory agencies have used these data to develop TEFs for the 2,3,7,8-substituted PCDDs and PCDFs (Table 4) , which are routinely detected as by-products ofindustrial and combustion processes and as residues in fish, wildlife, and human samples (75) (76) (77) (78) (79) . A conservative approach has been adopted for the selection of most of the individual TEF values, with particular emphasis on data obtained from long-term and reproductive studies. Safe (6) has also proposed a set of similar TEFs for these compounds in which the value for the 1,2,3,4,6,7,8-and 1,2,3,4,7,8,9-HpCDFs was increased to 0.1 due to the result of recent studies on the immunosuppressive effects of the compounds in C57BL/6 mice. Regulatory agencies have not yet developed TEFs for the 2,3,7,8-TCDD-like PCB congeners; however, tentative TEF values for the coplanar PCBs (Fig. 2) and their monoand di-ortho-substituted analogs have also been proposed (6) .
Applications and Limitations of the TEF Approach
One of the major applications of the TEF approach involves the conversion of analytical data into toxic or 2,3,7,8-TCDD equivalents (TEQs) in which X (congener concentration) x (congener TEF) = TEQs for that sample. For example, the results in Table 5 summarize the TEQs for the PCB, PCDD, and PCDF components of human milk fat extracts from Quebec, Canada (80) . The total TEQs for the PCDDs, PCDFs, and PCBs were 9.34, There is also evidence that the TEF approach can be used to predict the toxicity of PCDD and PCDF mixtures. For example, Eadon and co-workers (87) tested the toxicity of an extract that contained a complex mixture of PCDD and PCDF congeners. The high-resolution analytical data for these mixtures was converted into TEQs using the TEF factors and the TEQs for the PCDDs and PCDFs in the soot extract were 0.82 and 14.55 ppm, respectively. In parallel experiments, the extract was administered to guinea pigs and compared to the toxicity of 2,3,7,8-TCDD for several responses including thymic atrophy, body weight loss, increased serum triglycerides, decreased serum alanine aminotransferase levels, the formation of hepatocellular cytoplasmic inclusion bodies, and acute lethality. The results showed that for the soot extracts, ED50 values derived for these toxic responses from the in vivo studies was 19, 21, 5, 18, 10, and 2 ppm, respectively, with an average value of 12.5 ppm. The calculated TEQ from the analytical data using the TEF approach was 15.37, and this value was remarkably similar to the TEQs determined from the in vivo studies in guinea pigs. These data and results from other studies confirm the utility of the TEF/TEQ approach for the hazard and risk assessment of PCDDs and PCDFs. (93, 94) . These compounds, which typically contain two to three ortho, zero to two para and low meta chlorine substituents, decrease the dopamine content in brain tissues and in mammalian cells. The adverse environmental and human health impacts of these more highly orthosubstituted PCB congeners are unknown and require further investigation.
A number of different structural classes of PCBs also induce P450 activities that are not mediated through the Ah receptor (95, 96) . For example, several individual congeners, including 2,2',4,4'-tetraCB and 2,2',4,4',5,5'-hexaCB have been characterized as pure phenobarbital (PB)-type inducers and structure-induction studies suggest that compounds substituted in at least two para and two ortho substituents induce this type of monooxygenase enzyme activity. The potential adverse health effects of this class of PCBs has not been determined; however, like PB, these compounds cause hepatomegaly and exhibit activity as potential tumor promoters in short-term bioassays for carcinogenesis. For example, 2,2',4,4',5,5'-hexaCB promotes diethylnitrosamine-induced ATPasedeficient lesions in rat liver (97, 98) . Because the previous risk assessment of PCBs has been derived, in part, from carcinogenicity studies of specific PCB mixtures (99, 100) , it is important not only to assess the contribution of all structural classes of PCBs as carcinogens and anticarcinogens but also to determine whether PCB-induced carcinogenicity is due to the activity of these compounds as either promoters or initiators or a combination of the two. Thus, although a limited TEF approach may be warranted in some situations for assessing the risk of Ah receptor-mediated responses, the application of this procedure for PCB-induced carcinogenic effects requires further validation and more research.
The financial assistance of the National Institutes of Health (P42-ES04917) and the Texas Agricultural Experiment Station is gratefully acknowledged. S. Safe is a Burroughs Wellcome Toxicology Scholar.
